Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for papers: Targeting cancer evolution in the clinic

The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.

Special issue: Impact of genomics on precision public health

Our special issue on ‘The impact of genomics on precision public health’, guest edited by Muin Khoury and Kathryn Holt has now launched. 

Genetic variation in the Middle East

Ahmad Abou Tayoun and Heidi Rehm highlight the lack of genomic diversity in large-scale sequencing efforts and barriers to data sharing in the Middle East.

Transcriptome-wide profiles of circRNA-RBP interactions

Jakob Skou Pedersen and colleagues generate a catalog of circRNA-RBP interactions in ENCODE cell lines and find that these could play a regulatory role in bladder cancer.

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:


Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)


Focus: the Gut Microbiome

Read the latest papers on gut microbiota and disease across BMC flagship journals.

Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies
Zengliang Jiang​​​​​​​ et al.

Published in BMC Medicine 03 December 2020

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini​​​​​​​ et al.

Published in BMC Biology 09 June 2020

Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma​​​​​​​
Hechen Huang​​​​​​​​​​​​​​​​​​​​​ et al.

Published in Genome Medicine 23 November 2020

Lifestyle and the presence of helminths is associated with gut microbiome composition in Cameroonians​​​​​​​
Meagan A. Rubel​​​​​​​ et al.

Published in Genome Biology 25 May 2020

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier

Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler

A decade of Genome Medicine

Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda

See all article collections

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

  • Editorial Board
  • Editorial Team
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.